Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial حسب Cummings, J, Zweifel, M, Smith, N, Ross, P, Peters, J, Rustin, G, Price, P, Middleton, MR, Ward, T, Dive, C

Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial. حسب Cummings, J, Zweifel, M, Smith, N, Ross, P, Peters, J, Rustin, G, Price, P, Middleton, MR, Ward, T, Dive, C